Clinical photographs showed visible regrowth in areas of previous thinning
In a sub-analysis of more than 300 participants from a large clinical trial, individuals regained, on average, two-thirds of the weight they had lost within one year of stopping the medication
Despite its European-sounding name, SwissChems is a U.S.-based company located in New York
Extending the market monopoly on these drugs beyond the original patent term through abusive patent practices drives up prices and prolongs health inequities
Hence, government officials, pharmaceutical companies, physicians, and public health advocates need to come forward to collaborate and make an effective policy on the pricing, insurance coverage, manufacturing, distribution, and availability of these medications for the greater good of the people
What makes Contrave patient selection more restrictive, according to the post